| 期 |
标题 |
文件 |
| 卷 30, 编号 1/2 (2023) |
“Silent rival”: pharmacological correction of the pathology of small airways in asthma (focus on ciclesonide) |
|
|
Belotserkovskaya Y., Sinopalnikov A., Romanovskikh A., Smirnov I.
|
| 卷 30, 编号 12 (2023) |
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution |
|
|
Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.
|
| 卷 31, 编号 4 (2024) |
Updating anti-doping education to countering the use of stimulants |
|
|
Gaisina E., Kalyanova A., Lysov E., Gоskov A.
|
| 卷 31, 编号 4 (2024) |
Current issues about the morphological features of Creutzfeldt-Jakob disease (CJD): review article |
|
|
Kuznetsova M., Svishcheva M., Sidnyaev V.
|
| 卷 30, 编号 4/5 (2023) |
Current approaches to the treatment of functional constipation in children |
|
|
Ermolenko K., Kirilenko L., Dolgikh V.
|
| 卷 31, 编号 9 (2024) |
Algorithm for auditing the rationality of clinical practice of using antibiotics in hospitals for children |
|
|
Vlasova A.
|
| 卷 31, 编号 7 (2024) |
Algorithm for diagnosis and treatment of small-cell lung cancer (SCLC) |
|
|
Gordeeva O.
|
| 卷 31, 编号 7 (2024) |
Algorithm for diagnostics and systemic therapy of metastatic hormone-sensitive HER2-negative breast cancer |
|
|
Dashyan G., Olchonova A., Dzhelyalov E., Akhmedov R., Sereda O., Vats A., Zhurov A., Shaikhelislamova L., Pushkaruk G., Belousov A.
|
| 卷 32, 编号 4 (2025) |
Algorithm for the diagnosis and treatment of bronchial asthma |
|
|
Bontsevich R., Danilova M., Zavitkevich G.
|
| 卷 31, 编号 6 (2024) |
Allergic rhinitis and associated diseases in real clinical practice |
|
|
Revyakina V.
|
| 卷 31, 编号 3 (2024) |
Alternative non-hormonal methods for correcting menopausal disorders |
|
|
Boris D., Apolikhina I., Tarnaeva L.
|
| 卷 30, 编号 8 (2023) |
Amino acid replacement therapy as preparation and enhancement of the effectiveness of collagen-stimulating methods |
|
|
Svechnikova E., Morzhanaeva M., Gorskaya A.
|
| 卷 30, 编号 3 (2023) |
Amiodarone-induced thyrotoxicosis: a modern view of the problem |
|
|
Salukhov V., Kovalevskaya E.
|
| 卷 32, 编号 1 (2025) |
Amoxicillin+[clavulanic acid] in the treatment of lower respiratory tract infections |
|
|
Sinopalnikov A., Guchev I.
|
| 卷 31, 编号 9 (2024) |
Analysis of associations of polymorphic markers of the CYP2C9, AGTR1, AGT, ACE, CYP11B2 genes with the achievement of target blood pressure values in patients with newly diagnosed arterial hypertension 1-2 degree after 3 weeks of pharmacotherapy with angiotensin II receptor blockers |
|
|
Rebrova E., Shikh E.
|
| 卷 31, 编号 2 (2024) |
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus |
|
|
Demicheva T.
|
| 卷 32, 编号 2 (2025) |
Analysis of the prognostic quality of mortality predictors in patients with COVID-19 and comorbid background: a retrospective study |
|
|
Aramisova L., Zhurtova I., Khachmakhova E.
|
| 卷 31, 编号 3 (2024) |
Analysis of spontaneous reports of adverse drug reactions in children of different ages |
|
|
Zhdanova O., Batishcheva G., Perova N., Mubarakshina O., Cherenkova O., Neyno E.
|
| 卷 30, 编号 14 (2023) |
Analysis of the structure of comorbidities and pharmacotherapy in patients with a combination of atrial fibrillation and coronary heart disease |
|
|
Dubinina A., Kochetkov A., Vorobieva А., Eremina S., Mirzaev K., Ostroumova O.
|
| 卷 31, 编号 7 (2024) |
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice |
|
|
Fateeva A., Eliseeva E., Apanasevich V., Zaemskaya A.
|
| 卷 30, 编号 14 (2023) |
Analysis of the frequency of CYP2C9, AGTR1, AGT, ACE, CYP11B2 gene Polymorphisms occurrence in patients with newly diagnosed 1–2 degree arterial hypertension |
|
|
Rebrova E., Shikh E., Kazakov R., Melkonyan G., Kulagina N.
|
| 卷 30, 编号 6/7 (2023) |
Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer |
|
|
Pesotsky R., Semiglazov V., Krivorotko P., Tabagua T., Zernov K., Emelyanov A., Yerechshenko S., Amirov N., Mortada V., Ulrikh D., Levchenko V., Rychagov K., Zirov K., Evseev V.
|
| 卷 32, 编号 3 (2025) |
Analysis of the effectiveness of first trimester screening for fetal growth retardation in the krasnodar territory (cohort study) |
|
|
Penzhoyan G., Mingaleva N., Makukhina T.
|
| 卷 32, 编号 4 (2025) |
Analytical clinical and statistical assessments of examination and treatment of oncological diseases |
|
|
Samsonov Y., Kostin A.
|
| 卷 30, 编号 6/7 (2023) |
Anemia in adult cancer patients |
|
|
Teletaeva G., Degtiareva E., Protsenko S., Latipova D., Semenova A., Novik A., Semiglazova T.
|
| 卷 32, 编号 5 (2025) |
Anogenital psoriasis: literature review and clinical case |
|
|
Khryanin A., Alyavi S., Sokolovskaya A., Chernikova E., Rakhmatov A.
|
| 卷 31, 编号 6 (2024) |
Antiarrhythmic effects of sodium-glucose cotransporter-2 inhibitors: a review of studies and mechanisms of action |
|
|
Leonova M.
|
| 卷 30, 编号 14 (2023) |
Antibiotic-associated diarrhea: potentials for the use of synbiotics |
|
|
Trukhan D., Gudilin V.
|
| 卷 32, 编号 1 (2025) |
Anticoagulant therapy in elderly patients with atrial fibrillation and atrial flutter: the position of rivaroxaban |
|
|
Zakiev V.
|
| 卷 31, 编号 1 (2024) |
Arterial hypertension and cognitive impairment in elderly and senile patients: basic approaches to patient management |
|
|
Ostroumova O., Telkova S., Dzamihov K., Kochetkov A., Baronov S.
|
| 卷 30, 编号 4/5 (2023) |
Arterial hypertension in pregnant women: «comorbidity» or a risk factor for postoperative infectious complications? |
|
|
Korobkov N., Bakulina N., Maximov M.
|
| 卷 30, 编号 9/10 (2023) |
Association of arterial hypertension and periodontal disease: a review of new data |
|
|
Trukhan D., Sulimov A., Trukhan L.
|
| 卷 31, 编号 6 (2024) |
Association between CES1, CYP3A genetic polymorphisms and remdesivir hepatotoxicity in patients with COVID-19 |
|
|
Temirbulatov I., Abdullaev S., Denisenko N., Kryukov A., Tuchkova S., Mirzaev K., Averkov O., Vechorko V., Sychev D.
|
| 卷 31, 编号 6 (2024) |
Asthenia: diagnostic algorithm, therapeutic approach |
|
|
Shavlovskaya O.
|
| 卷 31, 编号 6 (2024) |
Atopic dermatitis: current treatment options |
|
|
Sokolovsky E., Kholodilova N., Monakhov K.
|
| 卷 31, 编号 5 (2024) |
Atopic dermatitis: modern ideas about etiology, pathogenesis and promising directions of pharmacotherapy (review) |
|
|
Dzhavakhyan M., Bobyleva V., Gribkova E., Zvereva V., Dul V., Dhavakhyan D., Markaryan A.
|
| 卷 32, 编号 1 (2025) |
Baloxavir is a new antiviral drug for the treatment of influenza recommended by WHO |
|
|
Leonova M.
|
| 卷 31, 编号 2 (2024) |
Safety of continuous glycemic monitoring system in patients after total duodenopancreatectomy in the early postoperative period. Single-center retrospective cohort study |
|
|
Farmanov A., Bublik E., Vinogradskaya O., Udovichenko O., Zilov A., Ryzhkova E., Egorov V., Fadeev V., Deunezheva S., Zhivov A., Tobianskaya I.
|
| 卷 31, 编号 4 (2024) |
Safety of direct oral anticoagulants in the treatment of atrial fibrillation in geriatric patients: focus on clinically relevant non-major bleeding |
|
|
Sychev D., Cherniaeva M., Rozhkova M., Moiseeva E., Pogodina A., Bayzel Y., Egorova L., Maslennikova O., Lomakin N.
|
| 卷 30, 编号 14 (2023) |
Bempedoic acid – a new drug in lipid-lowering therapy |
|
|
Leonova M.
|
| 卷 30, 编号 9/10 (2023) |
Benzodiazepines: classification, properties, quantification and monitoring |
|
|
Kuzmin I., Kravtsova O., Platova A., Miroshnichenko I.
|
| 卷 31, 编号 4 (2024) |
Bettolepsy. Literature review |
|
|
Struk M., Levitsky G.
|
| 卷 30, 编号 12 (2023) |
Biochemical markers of various subtypes of gestational diabetes |
|
|
Volkova N., Degtyareva Y., Davidenko I., Degtyareva Y., Avrutskaya V.
|
| 卷 30, 编号 11 (2023) |
Short-term and long-term results of robot-assisted cystectomy with various types of urine derivation in patients with urothelial carcinoma of the bladder |
|
|
Gritskevich A., Okhanyan V., Monakov D., Simonov A., Kochetov A., Karelskaya N., Polotbek Z., Rusakov I.
|
| 卷 31, 编号 6 (2024) |
Pain syndrome in children with chronic tonsillitis in the postoperative period |
|
|
Asmanov A., Pivneva N.
|
| 卷 31, 编号 9 (2024) |
Patient with cerebral microangiopathy |
|
|
Kamchatnov P., Cheremin R., Prikazchikov S., Skipetrova L., Chugunov A.
|
| 卷 30, 编号 14 (2023) |
Bronchiolitis in children: a series of clinical examples |
|
|
Bashkina O., Sergienko D., Kuznetsova T.
|
| 卷 32, 编号 3 (2025) |
Vaginal microflora as a factor influencing the success of embryo cryotransfer in women with repeated art failures |
|
|
Karmakova A., Kulakova E., Makarova N., Boris D., Kalinina E.
|
| 卷 32, 编号 3 (2025) |
Vaginal microbiome and HPV persistence: the role of bacterial vaginosis in cervical carcinogenesis |
|
|
Iurova M., Abakarova P., Mezhevitinova E., Aksenova A.
|
| 卷 31, 编号 5 (2024) |
Vaginal microbiome and the role of probiotics in maintaining women’s health |
|
|
Khryanin A., Knorring G.
|
| 卷 31, 编号 8 (2024) |
Vaccination against pneumococcal infection in patients with diabetes mellitus |
|
|
Tarasova A., Kostinov M., Novopoltseva E.
|
| 卷 31, 编号 8 (2024) |
Variant of development of comorbid condition with late diagnosis of pancreatogenic diabetes mellitus: clinical case |
|
|
Kudinova E., Davidenko I., Volkova N.
|
| 卷 30, 编号 1/2 (2023) |
Introduction of complementary feeding in premature children |
|
|
Ryumina I., Narogan M., Baybarina E.
|
| 卷 30, 编号 11 (2023) |
Venous thrombosis and malignant gynecological diseases: the place of direct oral anticoagulants in prevention |
|
|
Ulrikh E.
|
| 卷 30, 编号 1/2 (2023) |
Vertebrogenic cervical radiculopathy: modern approaches to diagnosis and treatment |
|
|
Levin O., Nikitina A., Nebozhin A.
|
| 卷 31, 编号 2 (2024) |
Relationship between sarcopenic obesity and bone density in elderly patients |
|
|
Bulgakova S., Sharonova L., Kurmaev D., Treneva E., Kosareva O., Dolgikh Y., Merzlova P.
|
| 卷 30, 编号 1/2 (2023) |
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid |
|
|
Polyakova O., Tkachenko Y., Ostroumova O.
|
| 卷 30, 编号 1/2 (2023) |
The relationship between obesity, vitamin D deficiency and osteoporosis, as well as methods for their correction |
|
|
Salukhov V., Kovalevskaya E.
|
| 卷 31, 编号 4 (2024) |
The relationship between the psychological status of patients who have undergone myocardial revascularization and exercise tolerance at the outpatient stage of rehabilitation (original article) |
|
|
Ivanchukova M., Lokhina T., Iskenderov B., Denisova A.
|
| 卷 30, 编号 13 (2023) |
Species diversity of the vaginal microbiota and local immune status in patients with recurrent bacterial vaginosis |
|
|
Aisaeva B., Dikke G., Abusueva Z., Gitinova P.
|
| 卷 31, 编号 2 (2024) |
Vildagliptin – 15 years in active service with diabetologists |
|
|
Pavlova M.
|
| 卷 30, 编号 9/10 (2023) |
The influence of genetic resistance to antiplatelet agents on clinical and laboratory parameters and outcomes in ST-segment elevation myocardial infarction |
|
|
Markhulia D., Popugaev K., Petrikov S., Kuzmina I., Gazaryan G., Kiselev K., Kosolapov D., Klychnikova E., Godkov M., Parkhomenko M., Kramarenko A., Golovanev S., Mirzaev K., Sychev D.
|
| 卷 30, 编号 4/5 (2023) |
The effect of pregnancy and thyroid hormones on the occurrence and course of extrasystole |
|
|
Vinogradova O., Rakhmatullov F., Ostanin M., Rakhmatullov R.
|
| 卷 32, 编号 2 (2025) |
The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children |
|
|
Sadykova D., Shaydullina M., Aksenova A., Galimova L.
|
| 卷 30, 编号 1/2 (2023) |
Influence of angiotensin-converting enzyme inhibitors on the structural and functional parameters of the heart and subjective parameters of the quality of life of patients with essential hypertension |
|
|
Nedvetskaya S., Tregubov V., Shubitidze I., Tregubova M.
|
| 卷 31, 编号 9 (2024) |
The influence of CYP3A5, CYP2D6, CYP2C19 and ABCB1 gene polymorphisms on the levels of minimum steady-state concentration of doxorubicin and troponin I in patients with breast cancer: an observational cross-sectional study |
|
|
Bagdasaryan A., Shikh E., Drozdov V.
|
| 卷 31, 编号 8 (2024) |
Extraosseous symptoms of primary hyperparathyroidism in the practice of a general practitioner |
|
|
Sharonova L., Bulgakova S., Dolgikh Y., Kosareva O., Merzlova P., Treneva E., Kurmaev D.
|
| 卷 31, 编号 2 (2024) |
Possibilities of vitamin-mineral complexes in adjuvant therapy of thyroid diseases |
|
|
Trukhan D., Viktorova I., Druk I.
|
| 卷 31, 编号 4 (2024) |
Possibilities of diagnosing latent tuberculosis infection using recombinant tuberculosis allergen in patients with rheumatological diseases |
|
|
Mordyk A., Romanova M., Nurgaleeva A., Bagisheva N., Shapran A., Moiseeva M., Shcherbakova L., Mazur A., Shatova P., Mordyk D., Kudlay D.
|
| 卷 31, 编号 8 (2024) |
Potentials for the use of azilsartan and spironolactone in patients with arterial hypertension and diabetes mellitus |
|
|
Ignatenko G., Bagriy A., Mikhailichenko E., Prikolota A., Mogilevskaya K., Sabelnikova Y., Belikov V.
|
| 卷 31, 编号 2 (2024) |
Treatment options for different subtypes of gestational diabetes |
|
|
Davidenko I., Volkova N., Degtyareva Y.
|
| 卷 31, 编号 7 (2024) |
The potential of SPECT/CT examination in detecting benign bone changes using clinical cases as an example |
|
|
Litvinenko A., Afanasyeva N.
|
| 卷 30, 编号 11 (2023) |
Possibilities of overcoming hormone resistance in patients with metastatic HR+ HER2- breast cancer using the drug alpelisib in various subgroups in real clinical practice |
|
|
Orlova R., Gluzman M., Vakhitova A.
|
| 卷 31, 编号 8 (2024) |
Possibilities of using insulin degludec in the treatment of diabetes mellitus in patients with previous ineffective insulin therapy: analysis of clinical cases |
|
|
Elsukova O.
|
| 卷 31, 编号 4 (2024) |
Possibilities of using meldonium in the treatment of subacute and chronic forms of cerebrovascular accident |
|
|
Prokopenko S., Koryagina T.
|
| 卷 31, 编号 2 (2024) |
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice |
|
|
Elsukova O., Nikitina E., Chuprova A., Kaysina O.
|
| 卷 32, 编号 5 (2025) |
Possibilities of presarcopenia and sarcopenia prevention in the face using synchronized radiofrequency technology and High-Intensity Facial Electrical Stimulation (HIFES) |
|
|
Svechnikova E., Morzhanaeva M., Artemyeva N.
|
| 卷 31, 编号 9 (2024) |
Possibilities of symptomatic treatment of skin itching |
|
|
Kholodilova N., Monakhov K.
|
| 卷 30, 编号 1/2 (2023) |
Possibilities of screening for asymptomatic atrial fibrillation in clinical practice |
|
|
Stepanenko I., Sopova D., Salukhov V., Zaslavskaya E., Tarasov V., Novikov I.
|
| 卷 31, 编号 5 (2024) |
Potential of topical tranexamic acid application in the treatment of post-traumatic hyperpigmentation and hematomas in patients with cosmetology profile |
|
|
Morzhanaeva M., Svechnikova E.
|
| 卷 31, 编号 9 (2024) |
Potential of topical antimicrobial therapy in acute bacterial sinusitis |
|
|
Nosulya E., Kim I., Tovmasyan A., Luchsheva Y., Yushkina M., Muzhichkova A.
|
| 卷 30, 编号 11 (2023) |
Possibilities of a pharmacogenetic approach to solving gynecological problems in patients taking tamoxifen: a literature review |
|
|
Golubenko E., Savelyeva M., Poddubnaya I., Korennaya V.
|
| 卷 31, 编号 7 (2024) |
Possibility of de-escalation of adjuvant chemotherapy in patients with colorectal cancer taking into account the ctDNA determination |
|
|
Deshkina T., Bolotina L., Kornietskaya A., Golubev P., Fedenko A., Kaprin A.
|
| 卷 30, 编号 14 (2023) |
Possibility of using a combination of interferon alpha-2b and a complex immunoglobulin drug for infectious diseases in children |
|
|
Belan E., Nikiforova E.
|
| 卷 31, 编号 7 (2024) |
Potentials for endoscopic and magnetic resonance diagnostic methods in assessing the radicality of chemoradiotherapy in patients with rectal cancer |
|
|
Salimova A., Makarova M., Besova N., Kuvshinov Y., Karasev I.
|
| 卷 30, 编号 3 (2023) |
Age-dependent aspects of informativeness of surrogate indices of insulin resistance in the formation of menopausal metabolic syndrome |
|
|
Ruyatkina L., Ruyatkin D., Shcherbakova L.
|
| 卷 31, 编号 6 (2024) |
Secondary prevention of venous thrombosis. Potential of sulodexide |
|
|
Golovanova O.
|
| 卷 31, 编号 8 (2024) |
Severe dyslipidemia as a result of hypopituitarism decompensation in a girl with a PROP1 gene defect: a case report |
|
|
Pankratova M., Ionitsy K., Raykina E.
|
| 卷 30, 编号 8 (2023) |
Pyoderma gangrenosum in inflammatory bowel disease |
|
|
Yakubovsky A., Sokolovskiy E.
|
| 卷 30, 编号 6/7 (2023) |
Gastrointestinal toxicity during therapy with 5-fluorouracil |
|
|
Yakimenko Y., Kutukov V., Antonyan V., Gaziev M.
|
| 卷 30, 编号 6/7 (2023) |
Gastrointestinal stromal tumors: prospects for drug therapy of metastatic or inoperable forms |
|
|
Abramov M., Tikhomirova T., Ryabishina O., Rumyantsev A., Tyulyandina A.
|
| 卷 32, 编号 5 (2025) |
Generalized pustular psoriasis. literature review and clinical experience with IL-17 inhibitor therapy |
|
|
Kokhan M., Keniksfest Y., Filimonkova N., Grishaeva E., Stukova E.
|
| 卷 31, 编号 5 (2024) |
Herpes virus infection and reproductive health disorders in women. Analytical review |
|
|
Khryanin A., Sturov V.
|
| 卷 30, 编号 3 (2023) |
Hypercalcemia as a manifestation of a mild form of hyperparathyroidism: a clinical case |
|
|
Zhurtova I., Zhurtova I., Khachmakhova E., Elgarova M.
|
| 卷 31, 编号 3 (2024) |
Hypersensitive pneumonitis in children. Clinical experience |
|
|
Sergienko D., Bashkina O., Kuznetsova T.
|
| 卷 31, 编号 5 (2024) |
Hyperuricemia as a marker of chronic systemic inflammation in the pathogenesis of psoriasis |
|
|
Vereshchagin E., Svechnikova E., Maksimova Y., Arutyunyan G., Artemyeva N., Devyatova A.
|
| 卷 30, 编号 3 (2023) |
Glucometer with a mobile application as a system for remote control of diabetes |
|
|
Koteshkova O., Dukhareva O., Demidov N., Antsiferov M., Golubeva Y.
|
| 卷 31, 编号 5 (2024) |
Hidradenitis suppurativa: on the issue of rational therapy |
|
|
Zilberberg N., Kokhan M., Kascheeva Y.
|
| 卷 30, 编号 14 (2023) |
Data in the treatment of colon cancer from real clinical practice in Tashkent, Uzbekistan |
|
|
Khakimova G., Tryakin A.
|
| 卷 32, 编号 2 (2025) |
Deintensification of insulin therapy in elderly patients with type 2 diabetes mellitus: impact on glycemic control and risk of hypoglycemia |
|
|
Glinkina I., Oderiy A., Galkina A., Berdygylydzhova G., Fadeev V.
|
| 1 - 100 的 576 信息 |
1 2 3 4 5 6 > >> |
